Seanna Vine

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
Boston, United States

Disclosure information not submitted.

Presentation(s):

• Impact of Risk Evaluation and Mitigation Strategies on Teratogenic Medications Among Publicly and Privately Insured Reproductive-Age Women

  Monday, August 26, 2024
  2:45 PM – 3:00 PM CEST

• Retention in Buprenorphine versus Methadone Treatment for Opioid Use Disorder in Pregnancy and Postpartum

  Tuesday, August 27, 2024
  9:00 AM – 9:15 AM CEST